Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Lung Neoplasms 4Breast Neoplasms 3Malignant Solid Neoplasm 2Hematopoietic and Lymphatic System Neoplasm 2Spondylitis, Ankylosing 1Smoking Cessation 1Pyloric Stenosis, Hypertrophic 1Psoriasis 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Mental Disorders 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Lupus Erythematosus, Systemic 1Leukemia, Myeloid, Acute 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Depressive Disorder 1Crohn Disease 1Colorectal Neoplasms 1Colitis, Ulcerative 1Carcinoma, Non-Small-Cell Lung 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Reactive 1Arthritis, Psoriatic 1Advanced Malignant Solid Neoplasm 1

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Psoriasis × Interviews as Topic × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡